ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Toronto Cleantech Capital Inc

Toronto Cleantech Capital Inc (YAY.P)

0.23
0.00
(0.00%)
Closed January 13 4:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.23
Bid
0.22
Ask
0.22
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
0.23
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
60,339,000
Dividend Yield
-
PE Ratio
-4.63
Earnings Per Share (EPS)
-0.05
Revenue
5.81M
Net Profit
-3M

About Toronto Cleantech Capital Inc

Sector
Glass Pd,made Of Purch Glass
Industry
Unit Inv Tr, Closed-end Mgmt
Headquarters
Quebec City, Quebec, Can
Founded
2024
Toronto Cleantech Capital Inc is listed in the Glass Pd,made Of Purch Glass sector of the TSX Venture Exchange with ticker YAY.P. The last closing price for Toronto Cleantech Capital was $0.23. Over the last year, Toronto Cleantech Capital shares have traded in a share price range of $ 0.00 to $ 0.00.

Toronto Cleantech Capital currently has 60,339,000 shares outstanding. The market capitalization of Toronto Cleantech Capital is $13.88 million. Toronto Cleantech Capital has a price to earnings ratio (PE ratio) of -4.63.

YAY.P Latest News

TSX Venture Exchange Stock Maintenance Bulletins

TSX Venture Exchange Stock Maintenance Bulletins Canada NewsWire VANCOUVER, BC, May 2, 2023 VANCOUVER, BC, May 2, 2023 /CNW/ - TSX VENTURE COMPANIES OCEANSIX FUTURE PATHS LTD...

Suspension de la négociation par l'OCRCVM - YAY.P

Suspension de la négociation par l'OCRCVM - YAY.P Canada NewsWire VANCOUVER, BC, le 2 mai 2023 VANCOUVER, BC, le 2 mai 2023 /CNW/ - L'OCRCVM a suspendu la négociation des titres...

IIROC Trading Halt - YAY.P

IIROC Trading Halt - YAY.P Canada NewsWire VANCOUVER, BC, May 2, 2023 VANCOUVER, BC, May 2, 2023 /CNW/ - The following issues have been halted by IIROC: Company: Toronto CleanTech Capital...

L'OCRCVM permet la reprise de la négociation - YAY.P

L'OCRCVM permet la reprise de la négociation - YAY.P Canada NewsWire VANCOUVER, BC, le 5 juill. 2021 VANCOUVER, BC, le 5 juill. 2021 /CNW/ - Reprise des négociations pour : Société :...

IIROC Trading Resumption - YAY.P

IIROC Trading Resumption - YAY.P Canada NewsWire VANCOUVER, BC, July 5, 2021 VANCOUVER, BC, July 5, 2021 /CNW/ - Trading resumes in: Company: Toronto CleanTech Capital Inc. TSX-Venture Symbol:...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

YAY.P - Frequently Asked Questions (FAQ)

What is the current Toronto Cleantech Capital share price?
The current share price of Toronto Cleantech Capital is $ 0.23
How many Toronto Cleantech Capital shares are in issue?
Toronto Cleantech Capital has 60,339,000 shares in issue
What is the market cap of Toronto Cleantech Capital?
The market capitalisation of Toronto Cleantech Capital is CAD 13.88M
What is the 1 year trading range for Toronto Cleantech Capital share price?
Toronto Cleantech Capital has traded in the range of $ 0.00 to $ 0.00 during the past year
What is the PE ratio of Toronto Cleantech Capital?
The price to earnings ratio of Toronto Cleantech Capital is -4.63
What is the cash to sales ratio of Toronto Cleantech Capital?
The cash to sales ratio of Toronto Cleantech Capital is 2.39
What is the reporting currency for Toronto Cleantech Capital?
Toronto Cleantech Capital reports financial results in CAD
What is the latest annual turnover for Toronto Cleantech Capital?
The latest annual turnover of Toronto Cleantech Capital is CAD 5.81M
What is the latest annual profit for Toronto Cleantech Capital?
The latest annual profit of Toronto Cleantech Capital is CAD -3M
What is the registered address of Toronto Cleantech Capital?
The registered address for Toronto Cleantech Capital is 1037 BD INDUSTRIEL, GRANBY, QUEBEC CITY, QUEBEC, J2J 2B8
Which industry sector does Toronto Cleantech Capital operate in?
Toronto Cleantech Capital operates in the UNIT INV TR, CLOSED-END MGMT sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SQGSpackman Equities Group Inc
$ 3.50
(354.55%)
59.45k
KLMKermode Resources Ltd
$ 0.01
(100.00%)
1.42M
GNFIGenifi Inc
$ 0.01
(100.00%)
2k
XBOTRealbotix Corp
$ 0.61
(84.85%)
6.9M
JADEJade Leader Corp
$ 0.04
(60.00%)
177k
AJAAJA Health and Wellness Inc
$ 0.035
(-53.33%)
2k
BYM.HBaymount Incorporated
$ 0.005
(-50.00%)
1,000
ETUE2gold Inc
$ 0.005
(-50.00%)
12.29k
ENTGEntourage Health Corp
$ 0.005
(-50.00%)
16.04k
WWA.PWhitewater Acquisition Corp
$ 0.14
(-48.15%)
5k
XBOTRealbotix Corp
$ 0.61
(84.85%)
6.9M
QNCQuantum Emotion Corp
$ 0.90
(-19.64%)
4.37M
GPUSAlset AI Ventures Inc
$ 0.185
(-11.90%)
4.1M
RHCRoyal Helium Ltd
$ 0.02
(0.00%)
3.47M
THRMTherma Bright Inc
$ 0.04
(-20.00%)
2.71M

Discussion

View Full Feed
sunspotter sunspotter 10 minutes ago
Glenn Miller’s still missing, and Emil Malak and Rich Inza are still crooks.
VPLM
Flobewan Flobewan 21 minutes ago
Marc loved your ides
tinojax tinojax 22 minutes ago
I usually enjoy a beer with my pizza...........I would like to know what's in the Kool Aid........
PLUG
mrfence mrfence 24 minutes ago
Here we are on the cusp of the Monsta $FMCC~ $FNMA~ Gains we've all been waiting for doin da Heebie Jeebie Dance, 😃😄😁😆😅😂!
[yt]MUB3ZR4F8vw?si=Z3oB5zc_RHMtCGEY[/yt]
FMCC FNMA
IVRT IVRT 40 minutes ago
In my opinion, there will likely be significant pressure on the share price leading up to the conference call. A sell-off could occur the day before, with the stock potentially bottoming out by the end of the investor call. I could be wrong, but I've seen similar patterns many times over the past 25
BMXI
DewDiligence DewDiligence 40 minutes ago
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

ENTA
DewDiligence DewDiligence 41 minutes ago
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

Guido2 Guido2 42 minutes ago
This is DUE DILIGENCE! Thank you Free Fannie.

https://x.com/freefannie/status/1878655047715991552?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ
FNMA
StockItOut StockItOut 49 minutes ago
That Xeriant PR excellently written with bullshit:

""After successfully completing 75% of the demanding NFPA 286 test," meaning = "after failing the NFPA 286 test by missing 25% of the approval target testing requirement,"

"the Company used the data to make several key
XERI
gitreal gitreal 52 minutes ago
You were actually partially right....BMXI has filed some SEC documents, some necessary (Form 1-A), some unnecessary (Form 4). And they do summarize a lot of the stuff that I think are fabrications....their production, mining operations, etc. Time will tell, but I think a lot of it (and probably
BMXI
RichieBoy RichieBoy 58 minutes ago
Jim wrote a blurb about seeking more US business.

Help you out any? 🤨
AFFU
DesktopDR DesktopDR 58 minutes ago
Any news or updates?
VPLM
Tahoe2468 Tahoe2468 1 hour ago
.0915 by Thursday....... 
KRTL
skitahoe skitahoe 1 hour ago
Remember GBM was redefined during the trial, thus some who were treated then had other forms of brain cancer. I believe the least we'll see in our label is brain cancer. Certainly GBM may be the deadliest of them, but treatment should work in all of them.

According to Google, GBM ha
NWBO
fuagf fuagf 1 hour ago
You are right about the crafty, evil, smart. Authoritarian methods have been in full view
in capturing America. While we work to do the right things they plot to capture the lot.
facts_matter14 facts_matter14 1 hour ago
If there weren’t suckers born every minute, there wouldn’t be POSRMX bag holders down as much as 99%, and there sure as hell wouldn’t be anybody believing there is a pipeline of products.






.
SRMX
StockItOut StockItOut 1 hour ago
Your "closer" keeps getting extended. Then again extended. Then again extended. -- Consider that end. Now expired, horizon end now reached, and the view clarifies and we see it to be your desperation from years ago ongoing still, to pump this at any expense, where you attempt to instill FOMO to hold
XERI
fuagf fuagf 1 hour ago
He would smother any question with words.
Shawonsarker84 Shawonsarker84 1 hour ago
$HMBL Sorry HMBL investors. XTIA now broke the record 2.7B share volume traded before the reverse split.



https://x.com/shawonsarker84/status/1878696680088019193?t=rZlhkn2Jos4vWKxxQgXGfA&s=19
HMBL XTIA
chen1992 chen1992 1 hour ago
https://www.energy.senate.gov/hearings/2025/1/hearing-to-consider-the-nomination-of-mr-chris-wright-to-be-secretary-of-energy

https://www.commerce.senate.gov/2025/1/full-committee-nomination-hearing_2#:~:text=U.S.%20Senator%20Ted%20Cruz%20(R,Wednesday%2C%20January%2015%2C%20
TGLO
FNM500K FNM500K 1 hour ago
Oh noooooo.....
FNMA
StockItOut StockItOut 1 hour ago
OTC filings and attorney statements. my error.

Point that it is on you to prove your claim, that:
"There's no contract employees. There's no production shafts."

Likewise for the company to do so, as we wait for an audit, apparently indefinitely.

I
BMXI
Money4Nothing-M4N Money4Nothing-M4N 2 hours ago
Definitely excited to hear about batch 5. I believe we should hear news very soon. if they began batch 5 immediately after batch 4 then 5 is overdue.

And in light of last week's PR about Darwin's Bark Dragline silk, I'm expecting KBLB to have the attention of the DOD once again.
KBLB
rx7171 rx7171 2 hours ago
Too bad no mention of the degree of brain atrophy of the Blar treated patients reverting to close to normal aging compared to the MAB treated patients having accelerated rate of atrophy.

To me this is a bio marker that sets the two therapies at extreme ends of the plus minus continuum
AVXL